Corcept Therapeutics
CORT
#2294
Rank
C$11.43 B
Marketcap
C$104.52
Share price
-5.67%
Change (1 day)
4.25%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): C$10.08 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are C$0.83 Billion. In 2025 the company made an earning of C$62.65 Million a decrease over its 2024 earnings that were of C$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$10.08 M-83.91%
2025 C$62.65 M-67.29%
2024 C$0.19 B27.66%
2023 C$0.15 B-4.75%
2022 C$0.15 B-9.51%
2021 C$0.17 B-2.91%
2020 C$0.17 B14.87%
2019 C$0.15 B24.71%
2018 C$0.12 B69.32%
2017 C$73.92 M419.26%
2016 C$14.23 M-395.64%
2015 -C$4.82 Million-87.53%
2014 -C$38.63 Million-33.44%
2013 -C$58.04 Million
2011 -C$45.22 Million17.84%
2010 -C$38.38 Million35.5%
2009 -C$28.33 Million2.84%
2008 -C$27.54 Million60.81%
2007 -C$17.13 Million-52.14%
2006 -C$35.79 Million20.91%
2005 -C$29.6 Million31.87%
2004 -C$22.45 Million60.54%
2003 -C$13.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.18 B 292,187.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$17.68 B 197,292.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$9.66 B 107,737.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$48.62 B 542,744.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.75 B 119,962.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$15.84 B 176,824.28%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-C$68.05 Million-859.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.11 B 1,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.20 B 2,228.02%๐Ÿ‡บ๐Ÿ‡ธ USA